Defunct Company
Total Trials
27
As Lead Sponsor
17
As Collaborator
10
Total Enrollment
3,112
NCT02721615
Injured Spinal Cord Pressure Evaluation
Phase: N/A
Role: Collaborator
Start: Sep 30, 2010
Completion: Apr 30, 2025
NCT01813591
A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2013
Completion: Nov 30, 2015
NCT02008123
Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant
Start: Aug 31, 2013
Completion: Not specified
NCT02158585
Study of Lamotrigine to Treat Ménière's Disease
Start: Jun 30, 2014
Completion: Mar 31, 2017
NCT02585635
Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia
Start: Mar 31, 2016
Completion: Feb 1, 2018
NCT03336762
Injured Spinal Cord Pressure Evaluation Study - Transverse Myelitis
Start: Feb 14, 2017
Completion: Aug 1, 2020
NCT03615638
Community-based Rehabilitation and Fall Prevention Program After Total Knee Arthroplasty
Start: Oct 1, 2018
Completion: Dec 31, 2021
NCT04241562
Validation of a Novel Cortical Biomarker Signature for Pain
Start: Nov 4, 2020
Completion: Oct 10, 2022
NCT04602858
The SafeTrip Study - Step Training to Reduce Falls in Older Adults
Start: Dec 1, 2020
Completion: Nov 19, 2023
NCT05420350
Lamotrigine and Bupropion for Meniere's Disease
Start: Dec 16, 2020
Completion: Dec 31, 2024
NCT04613141
The WalkingTall Study: Comparing WalkingTall With Parkinson's Disease (WalkingTall-PD) With Mobility-plus to Reduce Falls and Improve Mobility.
Start: Jul 15, 2021
Completion: Sep 28, 2022
NCT03846830
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
Start: Oct 11, 2021
Completion: Apr 1, 2025
NCT05219604
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
Phase: Phase 4
Start: Mar 15, 2022
Completion: Oct 4, 2022
NCT06378164
The Effect of Combined Volitional and Reactive Step Training in Reducing Falls Risk in Older Fallers
Start: Dec 1, 2023
Completion: Apr 30, 2026
NCT06167330
TITAN Trial: Reducing Phantom Limb Pain in People with Amputations
Start: Dec 18, 2023
Completion: Dec 18, 2027
NCT06282081
Serum Neurofilament Light in Multiple Sclerosis
Start: Apr 9, 2024
Completion: Mar 1, 2027
NCT06504433
The Natural History of Mitochondrial Diseases
Start: May 7, 2024
Completion: May 7, 2034
NCT06535646
Digital Health Technology for People With Mitochondrial Disease
Start: Sep 9, 2024
Completion: Feb 28, 2025
NCT06605248
NOTUS Feasibility Study: Reducing Chronic Low Back Pain With Mobile App Intervention
Start: Oct 8, 2024
Completion: Mar 13, 2025
NCT06871254
Spinal Cord Injury Neurorecovery Collaboration
Start: Mar 1, 2025
Completion: Dec 31, 2027
NCT06924255
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Start: Apr 30, 2025
Completion: Dec 31, 2025
NCT06345781
Abdominal Functional Electrical Stimulation to Improve Bowel Function in Spinal Cord Injury
NCT06984354
Digitally Delivered Treatments to Reduce Chronic Low Back Pain
Start: Jun 2, 2025
Completion: May 26, 2028
NCT06620133
Pain Education and Patient-led Goal Setting in Adults With Chronic Low Back Pain: a Randomised Controlled Trial
Start: Jun 9, 2025
Completion: Dec 31, 2029
NCT07057219
Steps Against the Burden of Parkinson's Disease
Start: Jul 9, 2025
Completion: Nov 30, 2026
NCT07205991
ADHERE Trial: Strategies to Improve Mobile App Adherence
Start: Sep 23, 2025
NCT06907485
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients
Start: Dec 31, 2025